What Quansys Biosciences does

Quansys Biosciences Inc. is a privately held biotechnology company founded in 2004 and headquartered in Logan, Utah, that develops and manufactures the Q-Plex multiplex ELISA platform for simultaneous quantification of up to 18 biomarkers in a single 96-well plate using chemiluminescent detection. The platform comprises printed-array Q-Plex multiplex and singleplex assay kits, the Q-View family of benchtop chemiluminescent imagers (LS, Pro, and Plus), and Q-View analysis software that performs curve fitting and quantitative reporting. Quansys sells to academic and institutional researchers studying cytokines, immune responses, and infectious disease, to pharmaceutical and biotechnology customers running preclinical and clinical biomarker studies, and to global health organizations through partners such as PATH, with additional revenue from OEM manufacturing, custom ISO 13485-certified assay development, sample testing services, and VidaCheck, a serological antibody testing affiliate. The company distributes globally through direct sales, an inside sales team, an international distributor network, and OEM partners including QuidelOrtho and Cayman Chemical, operating on a quote-based pricing model with one-time kit and hardware purchases, subscription software, and professional service fees.

Name

Quansys Biosciences

Legal name

Quansys Biosciences Inc.

Website

https://quansysbio.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Quansys Biosciences is a privately held biotech founded in 2004 in Logan, Utah, that develops and manufactures the Q-Plex multiplex ELISA platform, Q-View chemiluminescent imagers, and analysis software for academic researchers, pharmaceutical companies, and global health organizations, with additional OEM and custom assay development services.

Ownership category

akta.pro rank

Product category

Life Sciences Immunoassay Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Proteomics & Biomarker Analytical Testing (HLAGADAG), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• Multiplex ELISA kits
• Biomarker immunoassays
• Chemiluminescent imaging
• Life sciences reagents
• Custom assay development

Headquarters

HQ city

Logan

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Multiplex ELISA Assay Kits: Sale of Q-Plex™ multiplex ELISA kits that detect multiple biomarkers simultaneously. Each kit contains 96-well plates with printed arrays, detection reagents, substrates, calibrators, and buffers. Revenue is generated from one-time kit purchases with varying prices based onplexity (number of analytes) and species specificity.
2. Singleplex ELISA Kits: Sale of single-analyte ELISA kits for focused biomarker measurement. These complement multiplex offerings and allow researchers to add specific targets not included in standard panels.
3. Sample Testing Services: Laboratory services where customers mail samples to Quansys for testing using Q-Plex™ arrays. Results and statistical analyses are provided within two weeks. Offers convenience for customers without access to Q-View imagers.
4. Q-View™ Imaging Equipment: Sale of Q-View imagers (LS, Pro, and Plus models) and associated software licenses for capturing and analyzing Q-Plex assay data. Software available with free trial period followed by purchased license.
5. OEM Manufacturing & Customization: Custom assay development and OEM manufacturing services for partners seeking retail-ready multiplex kits using Q-Plex™ technology. Includes custom assay kits, custom assay printing, and full assay development services.
6. Q-View Software Licenses: Software licensing for Q-View™ analysis platform. Free trial available for first kit analysis; purchased license required thereafter to continue software use.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

Quansys Biosciences manufactures and sells Q-Plex™ multiplex ELISA assay kits that simultaneously quantify up to 18 biomarkers per well in a 96-well plate using proprietary chemiluminescent detection. The company complements these kits with Q-View™ chemiluminescent imaging systems (LS, Pro, and Plus models) and Q-View Software for quantitative data analysis, and offers custom assay development, OEM manufacturing, and mail-in sample testing services.

Product overview

Quansys Biosciences offers the Q-Plex multiplex ELISA technology platform, a fully quantitative assay system for simultaneous detection of multiple biomarkers. The core portfolio consists of Q-Plex Multiplex and Singleplex Assays (up to 18 analytes per well in 96-well plates) paired with Q-View Imagers (LS, Plus, and Pro models) and Q-View Software for chemiluminescent imaging and quantitative data analysis. The company provides complementary services including Sample Testing (mail-in testing), OEM Manufacturing, and Custom Assay Development (ISO 13485 certified). Accessories include the Chemiluminescent Training Kit, Qualification Plate, and Stripwell Kit formats for flexible testing workflows.

Differentiator

Problem solved

Functional benefit

Brands

• Q-Plex: Multiplex ELISA technology platform for simultaneous quantification of multiple analytes using arrays of up to 18 distinct capture antibody nano spots per well.
• Q-View

Products and services

• Q-Plex Multiplex Assays Plate-based multiplex ELISA arrays that quantitatively detect up to 18 biomarkers simultaneously in a single 96-well plate using chemiluminescent detection. Available for human, mouse, rat, NHP, bovine, and porcine species.
• Q-Plex Singleplex Assays Single-analyte ELISA assays in 96-well plate format for targeted measurement of individual biomarkers with chemiluminescent detection, complementing the multiplex product line.
• Q-View Imager LS

Quantifiable outcome

• Cost reduction of 50-80% compared to equivalent singleplex ELISAs
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered key partner, flagship partnership and affiliate/sister company.

• QuidelOrthokey partnerStrategic or Co-development PartnerQuidelOrtho utilizes Q-Plex technology to offer multiplex ELISA products including the MicroVue Complement Multiplex kit. The partnership enables QuidelOrtho to expand their diagnostic product portfolio using Quansys's validated multiplex platform technology.
• PATHflagship partnershipStrategic or Co-development PartnerPATH partnered with Quansys to launch the Q-Plex Human Environmental Enteric Dysfunction (11-Plex) diagnostic to accelerate interventions for EED, a gut disease affecting children in developing countries. PATH is a global organization focused on health equity and innovative solutions for low-resource settings.
• Cayman Chemicalkey partnerStrategic or Co-development PartnerCayman Chemical offers Q-Plex multiplex ELISA products alongside their catalog of biochemicals and assays. The partnership extends Cayman's life sciences research offerings with Quansys's validated multiplex technology.
• VidaCheckaffiliate/sister companyTechnology or IntegrationVidaCheck, LLC is an affiliate company that provides serological antibody testing services to individuals and companies. VidaCheck handles customer registration and distributes test results, while Quansys performs the laboratory testing and analysis. The companies share personnel and data systems.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bio-Techne (R&D Systems / ProteinSimple): R&D Systems (a Bio-Techne brand) is a leading supplier of singleplex and multiplex ELISA kits, Luminex panels, and proteomic reagents — overlapping closely with Quansys' biomarker assay catalog and customer base.
• Meso Scale Diagnostics (MSD): MSD's MULTI-ARRAY and U-PLEX platforms offer electrochemiluminescence-based multiplex immunoassays for cytokine and biomarker profiling, directly competing with Q-Plex in pharma/biotech and academic research.
• RayBiotech: RayBiotech offers antibody array-based multiplex ELISA kits (similar chemiluminescent workflow) for cytokine and biomarker profiling, with a comparable catalog and similar academic/biotech customer base as Quansys.
• Cell Signaling Technology (CST): CST offers a broad portfolio of ELISA and multiplex immunoassay kits for signaling-pathway and inflammation biomarkers, directly competing with Q-Plex in academic and translational research.
• Bio-Rad Laboratories (Bio-Plex): Bio-Rad's Bio-Plex multiplex immunoassay system uses Luminex bead technology to quantify up to 100 analytes per well — a direct head-to-head competitor in cytokine/biomarker panels and immunoassay kits.

Broad incumbents

• MilliporeSigma (Sigma-Aldrich / Merck KGaA): MilliporeSigma sells MILLIPLEX multiplex MAP kits and a wide range of ELISA reagents, competing with Quansys across both catalog assays and custom/biomarker services for life sciences researchers.
• Thermo Fisher Scientific (Invitrogen ELISA): Thermo Fisher's Invitrogen ELISA and ProcartaPlex multiplex portfolio serves the same pharma/academic researchers as Quansys, with the advantage of a global sales force, broad catalog, and bundled instruments.
• PerkinElmer (Revvity): Revvity/PerkinElmer sells AlphaLISA and other immunoassay platforms, plus chemiluminescent imaging and detection instruments that overlap with Quansys' Q-View Imager and assay portfolio.

Emerging players

• SomaLogic (now part of Standard BioTools): SomaLogic's SomaScan platform performs high-multiplex proteomic profiling via aptamer technology; an indirect but increasingly relevant competitor for biomarker-discovery spend that historically funded multiplex ELISA work.
• Olink Holding: Olink's Proximity Extension Assay (PEA) technology enables high-multiplex protein biomarker discovery; it competes with Q-Plex for biomarker-discovery budgets in pharma and large-scale population studies.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/quansysbio
• YouTubeyoutube.com/channel/UCZR4lhSPx7z40kzjKnpaWLw
• Facebookfacebook.com/quansysbio
• LinkedInlinkedin.com/company/751493

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quansys Biosciences